Thank you for your reply Jason but the Director won't be making a loss. I am thinking it has something to do with rules/influence/voting/ regarding the new proposed entity.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling